Labcorp Free Cash Flow 2010-2024 | LH
Labcorp annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Labcorp free cash flow for the quarter ending March 31, 2024 was -163.50, a year-over-year.
- Labcorp free cash flow for the twelve months ending March 31, 2024 was , a year-over-year.
- Labcorp annual free cash flow for 2023 was $0.875B, a 42.76% decline from 2022.
- Labcorp annual free cash flow for 2022 was $1.528B, a 44.94% decline from 2021.
- Labcorp annual free cash flow for 2021 was $2.775B, a 54.56% increase from 2020.
| Labcorp Annual Free Cash Flow |
| 2023 |
874.70 |
| 2022 |
1,528.00 |
| 2021 |
2,775.40 |
| 2020 |
1,795.70 |
| 2019 |
1,052.20 |
| 2018 |
975.70 |
| 2017 |
1,190.70 |
| 2016 |
949.00 |
| 2015 |
727.20 |
| 2014 |
536.90 |
| 2013 |
617.60 |
| 2012 |
670.80 |
| 2011 |
713.60 |
| 2010 |
762.30 |
| 2009 |
748.60 |
| Labcorp Quarterly Free Cash Flow |
| 2024-03-31 |
-163.50 |
| 2023-12-31 |
874.70 |
| 2023-09-30 |
462.00 |
| 2023-06-30 |
291.30 |
| 2023-03-31 |
43.10 |
| 2022-12-31 |
1,528.00 |
| 2022-09-30 |
973.30 |
| 2022-06-30 |
682.20 |
| 2022-03-31 |
239.80 |
| 2021-12-31 |
2,775.40 |
| 2021-09-30 |
2,105.20 |
| 2021-06-30 |
1,454.90 |
| 2021-03-31 |
1,064.80 |
| 2020-12-31 |
1,795.70 |
| 2020-09-30 |
1,079.50 |
| 2020-06-30 |
376.60 |
| 2020-03-31 |
104.20 |
| 2019-12-31 |
1,052.20 |
| 2019-09-30 |
608.70 |
| 2019-06-30 |
244.10 |
| 2019-03-31 |
75.50 |
| 2018-12-31 |
975.70 |
| 2018-09-30 |
611.50 |
| 2018-06-30 |
408.10 |
| 2018-03-31 |
107.30 |
| 2017-12-31 |
1,190.70 |
| 2017-09-30 |
717.50 |
| 2017-06-30 |
395.90 |
| 2017-03-31 |
154.50 |
| 2016-12-31 |
949.00 |
| 2016-09-30 |
546.30 |
| 2016-06-30 |
360.00 |
| 2016-03-31 |
58.70 |
| 2015-12-31 |
727.20 |
| 2015-09-30 |
427.60 |
| 2015-06-30 |
207.40 |
| 2015-03-31 |
-120.40 |
| 2014-12-31 |
536.90 |
| 2014-09-30 |
369.00 |
| 2014-06-30 |
245.40 |
| 2014-03-31 |
86.00 |
| 2013-12-31 |
617.60 |
| 2013-09-30 |
428.00 |
| 2013-06-30 |
245.70 |
| 2013-03-31 |
156.70 |
| 2012-12-31 |
670.80 |
| 2012-09-30 |
477.70 |
| 2012-06-30 |
316.60 |
| 2012-03-31 |
163.40 |
| 2011-12-31 |
713.60 |
| 2011-09-30 |
465.00 |
| 2011-06-30 |
328.10 |
| 2011-03-31 |
186.30 |
| 2010-12-31 |
762.30 |
| 2010-09-30 |
535.00 |
| 2010-06-30 |
391.60 |
| 2010-03-31 |
209.10 |
| 2009-12-31 |
748.60 |
| 2009-09-30 |
561.50 |
| 2009-06-30 |
337.10 |
| 2009-03-31 |
178.20 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$16.431B |
$12.162B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
